Summary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
Products
-
-
CompaniesMolnupiravirSun Pharma
Sun Pharma arm receives DCGI approval for Molnupiravir in India
by adminby adminSynopsis : – Sun Pharmaceutical Industries Limited announced that one of its wholly owned subsidiaries has received Emergency Use Authorization (EUA) from…
-
Agrochemicals
Rotam Expands Into New Markets with JOYA Herbicide Featuring Flumioxazin 51%.
by adminby adminSUMMARY: Rotam, a global leader in superior crop protection products, announces the launch of JOYA™, a versatile professional herbicide featuring the active…
-
Agrochemicals
Sun Pharma Plans to Launch Merck’s Covid pill Molnupiravir Under the Brand Name Molxvir® in India Soon.
by adminby adminKEYPOINTS Sun Pharmaceutical Industries is getting set to bring out its version of molnupiravir, the anti-viral drug from Merck Sharpe Dohme and…
-
Agro Science & Research
Sym-Agro and Asfertglobal Announce an Agreement of an Exclusive Distributorship.
by adminby adminSUMMARY: Sym-Agro with Asfertglobal has announced an exclusive distribution agreement, a leader in the production of biostimulants, biocontrol solutions, and crop stress…
-
AstraZenecaDapagliflozin
NICE issues Draft Recommendation for AstraZeneca`s Forxiga (Dapagliflozin) to Treat Adults with Chronic Kidney Disease
by adminby adminAbstract: The National Institute for Health and Care Excellence (NICE) has issued an Appraisal Consultation Document (ACD) for AstraZeneca’s Forxiga (Dapagliflozin) within…
-
Agro Science & ResearchAgrochemicalsAKVANO
Lipidor submits New Patent Application and Expands Collaboration with Cannassure using Lipidor’s AKVANO® Technology for Medicinal Cannabis Products.
by adminby adminKEYPOINTS: Lipidor submits a new patent application and expands collaboration with Cannassure using Lipitor’s innovative AKVANO technology for medicinal cannabis products AKVANO®…
-
Iptacopan
Novartis Pharmaceuticals UK awarded an Innovation Passport for Investigational Oral Therapy Iptacopan (LNP023)
by adminby adminSUMMARY: Iptacopan has been awarded the Innovation Passport for the treatment of C3 glomerulopathy (C3G) and is currently being investigated in a…
-
Intellectual Property (IP)Patents
Med-X, Inc. Receives Patent on Nature-Cide Insecticidal Soil Formulation
by adminby adminKeypoints Med-X, Inc. announced that the Company received Patent No. 11,147,266 B2 for its Nature-Cide Insecticidal Soil formulation. Med-X’s goal is to…